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The rBAT gene is responsible for L-cystine uptake via the
b0,(+)-like amino acid transport system in a "renal proximal
tubular" cell line (OK cells)
Abstract
Several studies have shown that the cRNA of human, rabbit, or rat rBAT induces in Xenopus oocytes
sodium-independent, high affinity uptake of L-cystine via a system b0,(+)-like amino acid exchanger.
We have shown that mutations in rBAT cause type I cystinuria (Calonge, M. J., Gasparini, P., Chillarón,
J., Chillón, M., Gallucci, M., Rousaud, F., Zelante, L., Testar, X., Dallapiccola, B., Di Silverio, F.,
Barceló, P., Estivill, X., Zorzano, A., Nunes, V., and Palacín, M. (1994) Nat. Genet. 6, 420-425;
Calonge, M. J., Volipini, V., Bisceglia, L., Rousaud, F., De Sanctis, L., Beccia, E., Zelante, L., Testar,
X., Zorzano, A., Estivill, X., Gasparini, P., Nunes, V., and Palacín, M. (1995) Proc. Natl. Acad. Sci. U.
S. A. 92, 9667-9671). Apart from oocytes, no other expression system has been used for transfection of
functional rBAT activity. Furthermore, the b0,(+)-like transport activity has not been clearly described
in the kidney or intestine. Here, we report that a "proximal tubular-like" cell line derived from opossum
kidney (OK cells) expresses an rBAT transcript. Poly(A)+ RNA from OK cells induced by system
b0,(+)-like transport activity in oocytes. This was hybrid-depleted by human rBAT antisense
oligonucleotides. A polymerase chain reaction-amplified cDNA fragment (approximately 700 base
pairs) from OK cell RNA corresponds to an rBAT protein fragment 65-69% identical to those from
human, rabbit and rat kidneys. We have also examined transport of l-cystine in OK cells and found
characteristics very similar to the amino acid exchanger activity induced by rBAT cRNA in oocytes.
Uptake of L-cystine was of high affinity, sodium-independent and shared with L-arginine and L-leucine.
It was trans-stimulated by amino acids with the same specificity as rBAT-induced transport activity in
oocytes. Furthermore, it was localized to the apical pole of confluent OK cells. To demonstrate that the
rBAT protein is functionally related to this transport activity, we have transfected OK cells with human
rBAT antisense and sense sequences. Transfection with rBAT antisense, but not with rBAT sense,
resulted in the specific reduction of rBAT mRNA expression and b0,(+)-like transport activity. These
results demonstrate that rBAT is functionally related to the L-cystine uptake via system b0,(+)-like in
the apical pole of the renal OK cell line.
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Several studies have shown that the cRNA of human,
rabbit, or rat rBAT induces in Xenopus oocytes sodium-
independent, high affinity uptake of L-cystine via a sys-
tem b0,1-like amino acid exchanger. We have shown that
mutations in rBAT cause type I cystinuria (Calonge, M.
J., Gasparini, P., Chillaro´n, J., Chillo´n, M., Gallucci, M.,
Rousaud, F., Zelante, L., Testar, X., Dallapiccola, B., Di
Silverio, F., Barcelo´, P., Estivill, X., Zorzano, A., Nunes,
V., and Palacı´n, M. (1994) Nat. Genet. 6, 420–425; Cal-
onge, M. J., Volipini, V., Bisceglia, L., Rousaud, F., De
Sanctis, L., Beccia, E., Zelante, L., Testar, X., Zorzano, A.,
Estivill, X., Gasparini, P., Nunes, V., and Palacı´n, M.
(1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9667–9671). Apart
from oocytes, no other expression system has been used
for transfection of functional rBAT activity. Further-
more, the b0,1-like transport activity has not been
clearly described in the kidney or intestine. Here, we
report that a “proximal tubular-like” cell line derived
from opossum kidney (OK cells) expresses an rBAT tran-
script. Poly(A)1 RNA from OK cells induced system b0,1-
like transport activity in oocytes. This was hybrid-de-
pleted by human rBAT antisense oligonucleotides. A
polymerase chain reaction-amplified cDNA fragment
(;700 base pairs) from OK cell RNA corresponds to an
rBAT protein fragment 65–69% identical to those from
human, rabbit and rat kidneys. We have also examined
transport of L-cystine in OK cells and found character-
istics very similar to the amino acid exchanger activity
induced by rBAT cRNA in oocytes. Uptake of L-cystine
was of high affinity, sodium-independent and shared
with L-arginine and L-leucine. It was trans-stimulated by
amino acids with the same specificity as rBAT-induced
transport activity in oocytes. Furthermore, it was local-
ized to the apical pole of confluent OK cells. To demon-
strate that the rBAT protein is functionally related to
this transport activity, we have transfected OK cells
with human rBAT antisense and sense sequences.
Transfection with rBAT antisense, but not with rBAT
sense, resulted in the specific reduction of rBAT mRNA
expression and b0,1-like transport activity. These re-
sults demonstrate that rBAT is functionally related to
the L-cystine uptake via system b0,1-like in the apical
pole of the renal OK cell line.
Human rBAT cDNA elicits high affinity sodium-independent
transport of cystine, dibasic amino acids, and some zwitterionic
amino acids via a b0,1-like transport system in Xenopus oocytes
(1, 2). Heteroexchange diffusion of these amino acids has been
reported for this transport activity expressed by rabbit (3, 4),
rat (5), and human1 rBAT cRNA in oocytes. rBAT protein is
expressed in the brush border plasma membrane of both the
proximal straight tubules of the nephron and the small intes-
tine (6, 7). Recent studies have demonstrated that mutations in
the human rBAT gene cause cystinuria (8–12). Cystinuria is a
common inherited aminoaciduria due to the defective transport
of cystine and dibasic amino acids through the epithelial cells of
the renal tubule and intestinal tract (13, 14). The clinical
manifestation of cystinuria is the development of kidney cys-
tine calculi resulting from the poor solubility of this amino acid
(14). Three types of classic cystinuria have been described on
the basis of the amino acid hyperexcretion of heterozygotes and
the degree of the intestinal transport defect (14–16). Very
recently, strong evidence has been offered suggesting that
rBAT is only responsible for type I (10, 12).
Due to the role of the rBAT gene in type I cystinuria, the
rBAT protein is considered to be responsible for the reabsorp-
tion of cystine and dibasic amino acids in the proximal straight
tubule. Two aspects of this remain to be clarified. First, a
complete picture of the b0,1-like transport activity responsible
for cystine reabsorption has not been described in the epithelial
cells of kidney or intestine. In renal brush border membrane
vesicles a high affinity system for cystine and dibasic amino
acids, which shows heteroexchange diffusion between these
substrates, has been demonstrated (17–19). This transport was
shown to be defective in biopsies of intestinal mucosa from
cystinuric patients (20–22). The sodium dependence of this
reabsorption system is controversial, as is its interaction with
neutral amino acids, since no hyperexcretion of neutral amino
acids occurs in cystinuria (17–19, 22–24). Second, the role of
rBAT in the b0,1-like transport mechanism is unknown. Evi-
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dence from Tate and co-workers (25) suggests a four-mem-
brane-spanning domain model for rBAT. This topology is un-
usual for metabolite transporters, which appear to contain
8–12 transmembrane domains (26). This fostered the idea that
rBAT is a regulatory subunit of an oligomeric transporter
rather than the transporter itself (27, 28). Indirect evidence
suggested that rBAT forms a heterodimeric structure of 125
kDa with an unidentified protein of 40–50 kDa in renal brush
border membranes and oocytes (29).2 In addition, transient
expression of rBAT in COS cells revealed either expression of
rBAT in the cell surface without concomitant amino acid trans-
port activity (30) or a protein product that does not reach the
plasma membrane.3 Thus, no cell system other than oocytes
has shown expression of amino acid transport activity associ-
ated with rBAT. It thus remains an open question whether the
amino acid transport activity associated with rBAT in the renal
epithelial cells is the same as that elicited by rBAT expression
in oocytes.
To this end we searched for the role of rBAT in the transport
of cystine in an epithelial cell line derived from proximal tu-
bules of the kidney of an American opossum, the cell line OK.
These cells express an mRNA transcript that hybridizes with
rBAT probes (27, 28), and they show high affinity sodium-
independent cystine-dibasic amino acid transport in the apical
pole (31). Here we demonstrate that OK cells express rBAT
mRNA and that the transport of cystine in the apical pole of
these cells is due to an amino acid transport system very
similar to the b0,1-like system elicited by rBAT in oocytes.
Transfection of rBAT antisense sequences results in the spe-
cific reduction of rBAT mRNA expression and b0,1-like trans-
port activity. This demonstrates that rBAT is responsible for
the high affinity sodium-independent L-cystine uptake shared
with dibasic and neutral amino acids (i.e. system b0,1-like)
present in the apical pole of the renal cell line OK.
MATERIALS AND METHODS
Cell Culture and Uptake Studies in OK Cells—Studies were per-
formed with the OK cell line clone 3B/2, derived by selection from the
original OK cells (32), between passages 16 and 21. This clone was
originally subcloned from the parental line for maximal response of
phosphate transport to low phosphate medium and to inhibition by
parathyroid hormone. Cells were grown in Dulbecco’s modified Eagle’s
medium/Ham’s F-12 medium (1:1) supplemented with 10% fetal calf
serum, as described (33). Subcultures were prepared by trypsinization
and reseeding at high density (approximately 1 3 106 cells/ml). Only
cells free of mycoplasma (Gene Probe Mycoplasma T.C. (Movaco) test
kit) were studied.
For transport studies, cells were used 5 days after plating (90–100%
confluence) on 35-mm diameter dishes, except for antisense studies, in
which 16-mm diameter wells were used. Growth medium was removed,
and dishes were washed three times in 3 ml of MGA4 medium (i.e. 137
mM N-methyl-D-glucamine (MGA), 5.4 mM KCl, 2.8 mM CaCl2, 1.2 mM
MgSO4, 10 mM HEPES; pH 7.4 at 37 °C) prewarmed to 37 °C. MGA was
replaced by 137 mM NaCl (sodium medium) in those experiments in
which the sodium-dependence was studied. Uptake media were pre-
pared by adding the labeled amino acid (L-[3H]arginine and
L-[3H]leucine from DuPont NEN or L-[35S]cystine from Amersham Corp;
final concentration, 0.5–1 mCi/ml) to MGA or sodium media. When
cystine was present, the uptake medium contained 5 mM diamide as an
oxidizing agent. Uptake was started by the addition of 1 ml (0.5 ml for
16-mm diameter wells) of uptake medium (at 37 °C) to the plate and
terminated by removing uptake medium from the plate and washing it
five times in cold stop solution (132 mM NaCl, 14 mM Tris/HCl, 5 mM
L-arginine, 5 mM L-leucine; pH 7.4 at 4 °C). For the three amino acids
used, uptake periods were previously assessed for all concentrations
studied and consequently the uptake period used was 30 s. Nonspecific
binding was assessed by measuring zero-time uptake, which was
achieved by adding the uptake medium and immediately removing it
and stopping the uptake. Cell lysates were obtained by adding 1 ml of
0.5% Triton X-100/plate (0.5 ml in 16-mm diameter wells). 150 ml of this
lysate was removed for scintillation counting in 3 ml of EcoLite1™
scintillation fluid (ICN), and 25 ml was used for protein determination
by the Lowry method (34). The zero point was subtracted from the 30-s
value, and uptake is expressed as nmol/mg proteinzmin. Previous stud-
ies demonstrated that after subtracting the zero value, the best fit line
passed through the origin (data not shown).
For trans-stimulation experiments, cells in a confluent 3.5-cm diam-
eter plate were preloaded for 2 min with 50 mM L-[3H]arginine or
L-[3H]leucine (0.5 mCi/ml). Afterward, they were washed in MGA me-
dium and 1 ml of MGA prewarmed medium was added to the plate.
From 15 s to 10 min, the efflux was monitored by removing aliquots (50
ml) periodically from the medium. The radioactivity contained in each
aliquot was quantified by liquid scintillation counting. Results are
expressed as (counts/min)/mg of protein/min. Efflux was linear for up to
1 min. Thin layer chromatography of the efflux medium in silica gel
using butanol/acetic acid/water (4:1:1, by volume) as a solvent, as de-
scribed elsewhere (35), revealed that ;95% of the efflux radioactivity
corresponds to L-arginine.
For transport polarity studies, OK cells were grown on Handmade
transwell filters (Nucleopore Corp. filtration products). A 1-cm diame-
ter polycarbonate tube was cut in 1-cm sections, and polycarbonate
filter membrane (0.1-mm pore size, 12-cm diameter, Nucleopore) was
glued with 1:1 cyclohexanone:chloroform to one side of each section. The
filters were dried, sterilized in 70% ethanol for at least 2 h, dried
overnight, and collagen-coated with (50 ml/filter) of rat tail collagen
(R-type, Serva; 0.5 mg/ml in 50% ethanol). Cells were seeded at high
density 1/1.3 from the final trypsinized volume (20 ml of cell suspen-
sion). 500 ml of medium was added to the basal surface. Cells were refed
1 day before the uptake, which was carried out 3 days after the seeding,
when cells had reached confluence. Transport measurements were per-
formed using the uptake medium described above for plastic cell dishes.
Both sides of the plastic transwell filters were thoroughly washed in
MGAmedium. For apical transport, in either the presence or absence of
sodium, basal side was immersed in MGA medium. Uptake was initi-
ated by the addition of 500 ml of the uptake medium to the correspond-
ing side of the filter. For basal transport, the same procedure was
followed, i.e. the apical side was immersed in MGA medium. Uptake
was stopped by aspirating the uptake solution and washing the filters
five times in the stop solution mentioned above. 100 ml of 0.5% Triton
X-100 was added to each filter, and, 30 min later, total radioactivity
incorporated into the monolayer was measured by liquid scintillation
counting of the whole filter immersed in 9 ml of scintillation fluid.
Results are expressed as pmol/30 s/filter.
Oocyte Studies—Oocyte management, injections, and amino acid up-
take measurements were described elsewhere (1). Xenopus laevis (H.
Ka¨hler, Institut fu¨r Entwicklungsbiologie, Hamburg, Germany) oocytes
were defolliculated by collagenase D (Boehringer Mannheim), and
healthy-looking stage VI oocytes were injected (Inject1Matic system, J.
A. Gabay, Geneva, Switzerland) with 50 nl of poly(A)1, cRNA, or water,
as described elsewhere (1). RNA was extracted from OK cells by the
guanidinium-thiocyanate-phenol-chloroform method as described (36).
Oligo(dT)-cellulose (Boehringer Mannheim) for the purification of
poly(A)1 RNA was used following the manufacturer’s protocol.
For hybrid depletion experiments, OK cell mRNA (0.7–1.0 mg/ml) or
human rBAT cRNA (0.01 mg/ml), prepared as described elsewhere (1),
were denatured at 65 °C for 5 min in a solution containing 50 mM NaCl
and 20 mM of a 20-mer sense or a 21-mer antisense oligonucleotide
complementary to the human (and rat) rBAT mRNA sequence (sense:
59-TGC CCA AGG AGG TGC TGT TC-39, starting at base 203 of the
coding region; antisense: 59-GAA CAG CAC CTC CTT GGG CAT-39,
starting at base 222 of the coding region) and further incubated at 42 °C
for 30 min prior to oocyte injection. In these conditions, human rBAT
cRNA-induced amino acid transport activity was specifically hybrid
depleted by .80% by the above mentioned antisense oligonucleotide
(data not shown).
PCR Amplification and DNA Sequencing—cDNA was synthesized in
a 20-ml reaction volume from a 1-ml RNA aliquot (poly(A)1 RNA from
OK cells at 1–3 mg/ml) and primed with 2.5 mM oligo(dT)16 (GeneAmp
RNA PCR kit; Perkin-Elmer). Incubation was for 60 min at 42 °C.
Reverse transcriptase was inactivated at 99 °C for 5 min. The 20-mer
oligonucleotides C4D (sense) and C5R (antisense), complementary to
the the human rBAT cDNA sequence, elsewhere described (8), were
used as primers for the PCR amplification that comprised: (a) an initial
denaturation at 95 °C for 3 min; (b) 5 cycles with denaturation at 95 °C
2 J. Chillaro´n and M. Palacı´n, unpublished results.
3 C. Mora and M. Palacı´n, unpublished results.
4 The abbreviations used are: MGA, N-methyl-D-glucamine; PCR,
polymerase chain reaction; bp, base pair(s); kb, kilobase pair(s); BCH,
2-amino-2-norbornane-carboxylic acid.
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for 35 s, annealing at 46 °C for 40 s, and extension at 74 °C for 70 s
(after annealing, temperature increased at a ramp rate of 12 °C/min);
and (c) 29 cycles with denaturation at 94 °C for 25 s, annealing at 56 °C
for 25 s, and extension at 74 °C for 70 s. The reaction buffer was
Perkin-Elmer Roche N808-0006 with 200 mM each dNTP, 0.6 mM of each
primer, 2.5 mM MgCl2, 10 ml of the reverse transcriptase reaction, and
2 units of Taq polymerase (Perkin-Elmer Roche) in 100 ml. This ampli-
fication yielded a fragment of ;700 bp as expected. The PCR product
was run in a 4% nondenaturing polyacrylamide gel, and the 700-bp
band was cut and eluted with 20 ml of distilled water. In order to obtain
large amounts of this fragment, 5 ml of the eluted product was used as
a template in a second round of PCR with the same primers and at high
stringency conditions for 34 cycles. After purification with Qiagen col-
umns (Qia Quick Spin PCR purification kit) this product was used for
automatic DNA sequencing and as a DNA probe for Northern analysis.
The purified C4D-C5R PCR-fragment was sequenced with the same
primers as for amplification and the internal primers C4R and C5D,
described elsewhere (8), using an automatic DNA sequencer (Applied
Biosystems model 373A) and Taq DyeDeoxy™ terminator cycle se-
quencing kit.
Permanent Transfection of OK Cells—A 669-bp EcoRI/ClaI (Klenow
blunt-ended) fragment from the full-length human rBAT cDNA (1),
comprising 43 bp of the 59 noncoding region, the ATG translation
initiation codon and 626 bp of the coding sequence (including two bases
of the codon for the amino acid residue Ile-209), was inserted in pcDNA3
mammalian expression vector (Invitrogen Corp.) polylinker previously
cut with (a) BamHI (Klenow blunt-ended)/EcoRI for antisense orienta-
tion or (b) XhoI (Klenow blunt-ended)/EcoRI for sense orientation. The
expression of both constructs was under the control of the constitutive
cytomegalovirus promoter. After transformation, antisense construct
clones and sense construct clones were isolated and constructions were
checked by restriction analysis.
For transfections and clone selection, confluent OK cell monolayers
(day 0) were trypsinized and seeded 1/7 in two 25-cm2 flasks. On day 1
(40–50% of confluence) cells were washed three times and then covered
with 3 ml of serum-free medium. Cells were then transfected by adding
dropwise 120 ml of DNA-Lipofectin mixture to each flask and swirling
gently. DNA-Lipofectin mixture (1:1, v/v) was prepared with human
rBAT sense or antisense constructs (45 mg/60 ml) and Lipofectin (30
mg/60 ml), following supplier’s protocol (Life Technologies, Inc.). Cells
were incubated with DNA-Lipofectin-containing medium for 16 h in a
humidified atmosphere of 5% CO2, 95% air at 37 °C. Medium was then
removed and replaced by complete medium (i.e. with 10% serum). Cells
were grown to confluence, trypsinized, and seeded in the presence of 0.4
mg/ml Geneticin (G418; Life Technologies, Inc.) to a very low density
(1/200) so that single clones could be isolated by picking the clones with
sterile trypsin-embedded cotton-sticks. G418-resistant clones were con-
tinuously grown in the presence of G418 (0.4 mg/ml). Screening of
positive clones expressing the sense or antisense human transcript was
performed by Northern blot analysis using BamHI fragment of human
rBAT cDNA cloned in pSPORT1 (1) .
Northern Blot Analysis—Total RNA from OK cells was transferred to
nylon membranes (Hybond N, Amersham) by capillarity in 10 3 stand-
ard saline citrate (SSC; 0.15 M NaCl and 0.015 M sodium citrate, pH 7.0)
after size separation on a 1.2% agarose/formaldehyde gel. RNA was
visualized with ethidium bromide to ensure that it was intact and
loaded in similar amounts and to confirm proper transfer. Blots were
prehybridized in 5 3 Denhardt’s (1 3 Denhardt’s: 0.02% polyvinylpyr-
rolidone, 0.02% Ficoll, 0.02% bovine serum albumin), 0.1% SDS, 5 3
SSPE (1 3 SSPE: 0.15 M NaCl, 1 mM EDTA, 10 mM NaH2PO4, pH 7.4),
200 mg/ml salmon sperm DNA, and 50% formamide, and hybridized in
the same solution containing 10% dextran sulfate at 42 °C. After hy-
bridization, blots were washed in 2 3 SSC for 10 min at room temper-
ature and then twice for 20 min in 0.4 3 SSC, 0.1% SDS at 55 °C. Two
cDNA probes were used, either a 2.2-kb BamHI fragment lacking 148
bp at the 59 end of the complete human rBAT cDNA (13) purified from
a 1% agarose gel using the PCR preps kit (Promega), or the PCR-
amplified OK cell rBAT fragment (C4D-C5R; see above) cut from a 1%
low melting agarose gel and purified by phenol/chloroform extraction
and ethanol precipitation. Hybridizations were visualized by autora-
diography (Agfa film, Currix RP2) using standard protocols. Probes
were labeled with [a-32P]dCTP (1 3 106 cpm/ml) by random oligonu-
cleotide priming (Boehringer Mannheim).
RESULTS
OK Cells Express the rBAT Gene—OK cells mRNA showed a
transcript of $2.3 kb that hybridized with a human rBAT
cDNA probe (data not shown). This agrees with previous stud-
ies that reported a transcript of similar size detected by North-
ern blot with rabbit or rat rBAT cDNA probes (27, 28). Cross-
reaction with the homologous cell surface antigen 4F2hc
transcript seems to be ruled out, since no hybridization signal
was obtained in OK cells mRNA using a human 4F2hc cDNA
(37) probe (data not shown). Poly(A)1 RNA from OK cells
expressed b0,1-like amino acid transport activity upon injection
in Xenopus oocytes. Thus, injection of mRNA from OK cells in
oocytes resulted in sodium-independent L-leucine uptake,
which was inhibited (.60%) by L-arginine (Fig. 1). Similarly,
oocytes injected with mRNA from OK cells showed expression
of sodium-independent uptake of 50 mM L-cystine (induced ac-
tivity over background of 2.6 6 0.7 pmol/30 min per oocyte) and
50 mM L-arginine (induced activity over background of 33.0 6
4.3 pmol/30 min/oocyte) uptake, which were inhibited (.60%)
by a 100-fold excess of L-leucine (data not shown). Hybrid
depletion of OK mRNA with an antisense oligonucleotide com-
plementary to the human (and rat) rBAT cDNA specifically
blocked (i.e. the sense oligonucleotide had no effect) expression
of sodium-independent L-leucine uptake to the level inhibited
by a 100-fold excess of L-arginine (Fig. 1). Similarly, OK
mRNA-expression of sodium-independent L-arginine uptake in-
hibitable by L-leucine was hybrid-depleted (.90%) specifically
by the same antisense oligonucleotide in oocytes (data not
shown). These results demonstrate the functional expression of
rBAT mRNA in OK cells. To provide further evidence for such
expression, we searched for a partial sequence of rBAT cDNA
in OK cells. RT-PCR from OK cell RNA, using oligonucleotides
(C4D, sense; C5R, antisense; described in Ref. 8) complemen-
tary to the human rBAT cDNA, yielded a specific fragment of
;700 bp (data not shown). The nucleotide sequence of this
fragment shows significant homology to human (74%), rabbit
(74%), and rat (70%) rBAT cDNA (data not shown). The pre-
dicted amino acid sequence of this OK cell fragment covers
amino acid residues 373–593 of the predicted human rBAT
FIG. 1. rBAT antisense hybrid depletion of the L-arginine-in-
hibitable L-leucine uptake induced by OK cells mRNA in oo-
cytes.Oocytes were injected with water containing 0 or 35 ng of OK cell
mRNA. Prior to injection, mRNA was incubated alone (Control) or in
the presence (20 mM) of a human rBAT antisense or sense oligonucleo-
tide. Five days after injection, uptake of 50 mM L-leucine was deter-
mined for 30 min incubations and either in the absence or in the
presence of 5 mM L-arginine. Each data point is the mean 6 S.E. of the
values (pmol/30 min/oocyte) of OK cell mRNA-induced L-leucine uptake,
calculated by subtracting the uptake values obtained in water-injected
oocytes from the uptake values in poly(A)1 RNA-injected oocytes. Up-
take of L-leucine in water-injected oocytes were 7.3 6 0.5 and 7.4 6 0.3
pmol/30 min/oocyte in the absence or in the presence of L-arginine,
respectively. Results were obtained with 6–8 oocytes per condition in a
representative experiment. Another independent experiment showed
similar results. The antisense effect and the L-arginine inhibition in the
control and sense groups, but not in the antisense groups, were statis-
tically significant (Student’s t test; p # 0.01).
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protein and the second and third putative transmembrane
domains in the topology model proposed by Tate and co-work-
ers (25) (Fig. 2). Homology of this predicted protein fragment to
human, rabbit, and rat rBAT cDNA ranged between 70% and
72% identity (84–86% similarity). Two out of three potential
N-glycosylation sites present in the human, rabbit, and rat
rBAT protein are conserved in the predicted OK cell rBAT
protein fragment (Fig. 2). Regions with maximal homology
between the four predicted protein fragments are those corre-
sponding to the second and third putative transmembrane
domains and around the second N-glycosylation site of the
protein fragments. The region comprising the second putative
transmembrane domain corresponds to one of the fragments
highly conserved between rBAT and 4F2hc predicted proteins
(38). These results demonstrate that OK cells express the rBAT
gene.
OK Cells Express b0,1-like Amino Acid Transport Activity in
the Apical Pole—OK cells, grown on plastic, showed uptake of
L-cystine, L-arginine, and L-leucine in the absence of sodium
(Fig. 3). Most of the 50 mM L-cystine uptake was sodium-inde-
pendent (;80%) (MGA medium: 1.39 6 0.07 nmol/mg
proteinzmin, n 5 8; sodium medium: 1.87 6 0.05 nmol/mg
proteinzmin, n 5 8). This is in full agreement with a previous
report of L-cystine uptake in OK cells (31). Approximately half
(;55%) of the L-leucine uptake was sodium-independent (MGA
medium: 6.37 6 0.09 nmol/mg proteinzmin, n 5 3; sodium
medium: 11.5 6 0.6 nmol/mg proteinzmin, n 5 3). Uptake of
L-arginine was completely sodium-independent (MGA medium:
11.2 6 0.5 nmol/mg proteinzmin, n 5 5; sodium medium: 9.6 6
1.1 nmol/mg proteinzmin, n 5 5).
The sodium-independent uptake of L-cystine, and part of the
L-arginine and L-leucine uptake, showed a pattern of substrate
inhibition very similar to the b0,1-like transport activity elic-
ited by rBAT in oocytes (27). Thus, L-cystine uptake was almost
completely abolished by a 100-fold excess of L-arginine and
L-leucine in the uptake medium; in contrast, L-glutamate did
not affect L-cystine transport, precluding expression of system
XC2 (Fig. 3). Similarly, the uptake of L-arginine was strongly
inhibited (70–80%) by a 100-fold excess of L-leucine (Fig. 3),
and the uptake of L-leucine was partially inhibited (60–70%) by
a 100-fold excess of L-arginine (Fig. 3). The non-metabolizable
amino acid analog BCH, a substrate model for system L, par-
tially inhibited L-leucine uptake (20–40%). This suggests that
part ([mteq]30%) of L-arginine and L-leucine uptake is due to
transport activities resembling systems y1 and L, respectively.
On the other hand, interaction of L-leucine with sodium-inde-
pendent L-arginine uptake suggests system b0,1-like or system
y1L transport activities (27, 38, 39). Inhibition of 50 mM L-
arginine uptake by varying concentrations of L-leucine (100 mM
to 10 mM) was identical in the absence and in the presence of
sodium (data not shown). This strongly indicates that the up-
FIG. 2. Comparison of the predicted and partial amino acid
sequence of OK cell rBAT protein with the human, rabbit, and
rat counterparts. The first line shows the OK cells rBAT amino acid
sequence. Below, only substituted amino acids in the sequences of
human (second line), rabbit (third line), and rat (fourth line) rBAT
proteins are shown. Amino acid gaps in the sequence are indicated by
dashes. This fragment of the OK cell rBAT protein is 220 amino acid
residues long and in this alignment starts at the amino acid residue 373
of the human rBAT protein. This fragment of the OK cells rBAT protein
is 72%, 71%, and 70% identical (85%, 86%, and 84% similarity) to the
human, rabbit, and rat rBAT protein fragment, respectively. Two pu-
tative transmembrane domains, corresponding to the second and third
domains of the four-transmembrane-domain model for the rBAT pro-
tein proposed by Tate and co-workers (27) are underlined in the OK cell
protein sequence. Two (OK cell protein) and three (human, rabbit, and
rat proteins) potential N-glycosylation sites are boxed.
FIG. 3. Sodium-independent uptake of amino acids in OK cells.Uptake of 50 mM L-[35S]cystine, L-[3H]arginine, or L-[3H]leucine by OK cells
were measured in the absence (Control) or in the presence of the indicated unlabeled L-amino acids at 5 mM concentration in the uptake MGA
medium. Uptake values (nmol/mg proteinzmin) are the mean 6 S.E. from 5–12 determinations from two to four independent experiments. All the
inhibitions shown were statistically significant (Student’s t test at least p # 0.01) with the exception of L-cystine transport in the presence of
L-glutamate.
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take of L-arginine is not due to y1L activity. Studies using
L-cystine as inhibitor are difficult to perform due to the low
solubility of this amino acid. For this reason we analyzed the
effect of L-cystine on the uptake of L-arginine and L-leucine at
low concentration. The uptake of 5 mM L-arginine (1.28 6 0.06
nmol/mg proteinzmin) was inhibited (23%) by 450 mM L-cystine
(0.99 6 0.02 nmol/mg proteinzmin) and to a similar extent by
450 mM L-leucine (1.00 6 0.09 nmol/mg proteinzmin). Similarly,
the uptake of 5 mM L-leucine (0.73 6 0.07 nmol/mg proteinzmin)
was inhibited (27%) by 450 mM L-cystine (0.53 6 0.01 nmol/mg
proteinzmin). In all, these results show that, in OK cells, uptake
of L-cystine is mostly due to the system b0,1-like activity, and
that the uptake of L-arginine and L-leucine in the absence of
sodium is due both to system b0,1-like and, probably, systems
y1 and L, respectively.
Kinetic analysis of L-cystine uptake, examined over a range
of concentration from 5 mM to 450 mM, showed apparent Km and
Vmax values of 370 6 40 mM and 13.6 6 1.0 nmol/mg
proteinzmin, respectively (data not shown). In agreement with
a previous report on OK cells (31), one high affinity system
appears to be present in OK cells. Kinetic analysis of L-arginine
and L-leucine was performed over the range of 5 mM to 1000 mM.
For arginine, one single kinetic component was observed with
apparent kinetic parameters of Km 211 6 48 mM and Vmax 59.9
6 6.6 nmol/mg proteinzmin for L-arginine (data not shown). For
the uptake of L-leucine inhibitable by 5 mM L-arginine, the
apparent kinetic parameters were: Km 175 6 56 mM and Vmax
20.8 6 2.5 nmol/mg proteinzmin (data not shown). These low
apparent Km values for L-cystine, L-arginine, and L-leucine are
of the same order (slightly higher) as those reported for these
amino acids via the b0,1-like amino acid transport system elic-
ited by human, rabbit, and rat rBAT cRNA in Xenopus oocytes
(1, 2, 27, 28, 40).
Recently, it has been reported that system b0,1-like ex-
pressed by rBAT in oocytes shows trans-stimulation, suggest-
ing that this transport system is an amino acid exchanger
(3–5). To provide further evidence for the presence of system
b0,1-like transport activity in OK cells, we searched for trans-
stimulation of L-arginine efflux by different amino acids. Efflux
was very low in the absence of amino acids (;1% of the total
2-min loading of L-[3H]arginine) but was increased by amino
acid substrates of system b0,1-like in the external medium:
17-fold by 1 mM L-arginine, 6-fold by 1 mM L-leucine, and .2-
fold by 200 mM L-cystine (Fig. 4). In contrast, L-arginine efflux
was not trans-stimulated by 1 mM L-glutamate in the external
medium (Fig. 4). The finding that most (;70%) of the L-argi-
nine uptake in OK cells was due to system b0,1-like activity and
that y1L activity was not present in these cells indicates that
trans-stimulation of L-arginine efflux by L-leucine is due to
system b0,1-like. Similarly, L-leucine efflux was trans-stimu-
lated by 1 mM L-arginine (6-fold) and by 300 mM L-cystine
(2.5-fold) (data not shown), also showing trans-stimulation
with characteristics of system b0,1-like.
Finally, we investigated the polarity of system b0,1-like ac-
tivity in OK cells grown on transwell filters. Sodium-independ-
ent L-cystine (Fig. 5) and L-arginine (data not shown) uptake
were higher (6–8-fold) in the apical pole. This is in full agree-
ment with a previous report of L-cystine uptake on OK cells
(31). Interestingly, the uptake of L-cystine and L-arginine in the
apical but not in the basolateral pole showed the characteristic
inhibition pattern of system b0,1-like; L-cystine uptake was
abolished by a 100-fold excess of L-arginine (Fig. 5), and the
uptake of L-arginine was strongly inhibited (,80% inhibition)
by a 100-fold excess of L-leucine (data not shown). In all, these
results demonstrate that OK cells express system b0,1-like
amino acid transport activity in the apical pole.
Transfection of rBAT Antisense Results in a Specific Decrease
of System b0,1-like Transport Activity in OK Cells—In order to
demonstrate that the rBAT gene was responsible for system
b0,1-like amino acid transport activity in OK cells, we per-
formed rBAT cDNA antisense expression in these cells. After
transfection with 59-end fragments of human rBAT cDNA an-
tisense or sense and Geneticin selection, cell clones were
searched for expression of the transfected constructs. Two
clones were positive for antisense transcript expression, and
two others for sense expression (data not shown). Expression of
endogenous rBAT mRNA in these clones was studied with the
PCR-amplified fragment rBAT cDNA from OK cells shown in
Fig. 2 as a probe. In comparison with control (i.e. untransfected
cells), the rBAT mRNA levels were lower in two antisense
FIG. 4. Trans-stimulation of arginine efflux in OK cells. Cells
were preloaded with 50 mM L-[3H]arginine for 2 min, then the medium
was washed out and L-[3H]arginine efflux was measured for 45 s in
media containing no amino acids (none) or the indicated L-amino acids
at 1 mM, except for L-cystine, which was present at 200 mM. Efflux rates
(mean 6 S.E.) are counts/min (3 1000) measured in the medium/mg
proteinzmin from triplicates from a representative experiment. Efflux
rates in the L-cystine, L-leucine, and L-arginine groups were statistically
different (Student’s t test; p # 0.05) from those of the none and L-
glutamate groups. Another five independent experiments gave similar
results. FIG. 5. Polarity of the arginine-inhibitable cystine uptake in
OK cells. Uptake of 50 mM L-[35S]cystine by OK cells grown on filters
was measured through the apical or basolateral poles, and in the
absence (open bars) or in the presence (filled bars) of 5 mM unlabeled
L-arginine. Uptakes were determined in the absence of sodium (MGA
medium). Uptake values (pmol/min/filter) are the mean 6 S.E. from
triplicates in a representative experiment. Amino acid uptake inhibi-
tions in the apical pole were statistically significant (Student’s t test; p
# 0.01). Another independent experiment showed similar results.
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clones (AS1 and AS2; ;20% and ;50% of control values, re-
spectively) and unaffected in the two sense clones (S1 and S2).
Expression of the transfected constructs and the rBAT mRNA
levels in antisense AS1 and sense S1 clones, as well as in
control cells (i.e. untransfected) are shown in Fig. 6A. An initial
screening for amino acid transport activity in these clones
revealed a decreased L-arginine transport activity in the anti-
sense clones, which showed reduced rBAT mRNA expression.
Thus, 50 mM L-arginine uptake in MGA uptake medium, ex-
pressed as nmol/mg proteinzmin, was: 11.0 6 0.5 for control
untransfected cells, 10.5 6 0.3 and 9.5 6 0.5 for S1 and S2
sense clones, and 6.0 6 0.4 and 6.6 6 0.3 for AS1 and AS2.
Similar results were obtained for L-leucine uptake (data not
shown).
Cell clones AS1 (antisense) and S1 (sense) were used for
further experiments in which system b0,1-like activity was
studied. Consistently (i.e. from passage 20 to 22), b0,1-like
transport activity was lower (40–55%) in the AS1 antisense
clone than in the S1 sense clone (Fig. 6B). System b0,1-like
transport activity was almost identical in the S1 sense clone
and in control untransfected cells (Figs. 3 and 6B). The b0,1-
like transport activity expressed by rBAT cRNA in oocytes
shows hetero-exchange between L-arginine and L-leucine (3–5).
This has also been suggested for this transport activity in OK
cells in the present study (Fig. 4). In order to demonstrate that
rBAT is responsible for this activity via b0,1-like transporter,
trans-stimulation of L-arginine efflux by L-leucine was studied
in AS1 antisense and S1 sense clones. This trans-stimulation
was reduced to ;50% in the AS1 antisense clone. Thus, efflux
(cpm/mg proteinzmin, corrected for the radioactivity loading
after 2 min of 50 mM L-[3H]arginine of 85,000 cpm/mg protein)
was 1,300 6 1,100 and 1,200 6 600 in the presence of 1 mM
L-glutamate in the medium for S1 sense and AS1 antisense
clones, respectively. This efflux was trans-stimulated to 17,500
6 900 and 9,200 6 300 by 1 mM L-leucine in the medium of S1
sense and AS1 antisense cells, respectively (data are mean 6
S.E. of triplicates from a representative experiment). In con-
trast to system b0,1-like transport activity, the uptake of L-
leucine inhibited by the amino acid analog BCH, model for
system L, was unaffected in the AS1 antisense clone (Fig. 6B).
Similarly, the sodium-dependent uptake of 50 mM L-leucine was
not affected in the antisense AS1 clone (i.e. the uptake values
from triplicates of a representative experiment were: 4.7 6 1.4
and 4.0 6 0.7 nmol/mg proteinzmin for the S1 sense and the
AS1 antisense clones, respectively). This demonstrates that
rBAT antisense expression in OK cells results in a specific
decrease in system b0,1-like transport activity. Kinetic analysis
of L-cystine uptake showed that rBAT antisense expression
reduces the apparent Vmax (7.8 6 0.8 and 3.5 6 0.7 nmol/mg
proteinzmin, for the S1 sense and the AS1 antisense clones,
respectively) without a significant effect on the estimated ap-
parent Km values (227 6 39 and 285 6 50 mM, for the S1 sense
and the AS1 antisense clones, respectively) (Fig. 7).
DISCUSSION
Here we have shown that system b0,1-like is the major com-
ponent of the transport of cystine in the apical pole of the
opossum kidney cell line OK. This system is very similar to the
exchanger activity of amino acids elicited by rBAT cRNA in
oocytes. In addition, we have demonstrated that rBAT expres-
sion is necessary for this b0,1-like amino acid transport activity
in this renal epithelial cell line. Due to the role of human rBAT
gene in type I cystinuria (8, 10, 12), a corollary of the present
study is that the b0,1-like amino acid exchanger would be
defective in this type of cystinuria.
Identification of the amino acid transport activity associated
with rBAT in renal cells has so far been elusive. No functional
FIG. 6. A, Northern blot analysis for human rBAT-sense and anti-
sense expression and for the endogenous rBAT mRNA in transfected
OK cells. A human rBAT cDNA probe hybridized to a transcript of ;1.2
kb in length, which is present in the RNA from OK cells transfected
with rBAT-sense or rBAT-antisense, but absent in nontransfected cells
(OK) (left panel). 30 mg of total OK cell RNA was loaded in each lane. An
OK cell rBAT cDNA probe, corresponding to the PCR-amplified cDNA
fragment shown in Fig. 2, hybridized with a transcript of .2.3 kb
present in non transfected OK cells (control) and in rBAT-sense and
rBAT-antisense OK transfected cells total RNA (middle panel). 30 mg of
OK cell total RNA was loaded per lane. The level of rBAT mRNA was
reduced in the OK cells transfected with rBAT-antisense to ;20% of
that in control and rBAT-sense groups, as revealed by scanning densi-
tometry in two independent Northern blot analyses. Ethidium bromide
staining of the Northern blot membrane shown in the middle panel
(right panel). B, amino acid uptake in OK cells transfected with human
rBAT sense or antisense. Uptake of 50 mM L-[35S]cystine, L-[3H]arginine,
or L-[3H]leucine by OK cells was measured in the absence or in the
presence of the indicated unlabeled L-amino acids or the amino acid
analog BCH at 5 mM concentration in the uptake MGAmedium. Uptake
values (nmol/mg proteinzmin) correspond to the uptake inhibited by the
indicated amino acids or analog and are the mean 6 S.E. from tripli-
cates of a representative experiment. Total uptake values (i.e. in the
absence of inhibitors) in the sense and antisense groups were, respec-
tively: 1.50 6 0.10 and 0.61 6 0.03 nmol/mg proteinzmin for L-cystine
uptake, 10.5 6 0.3 and 6.0 6 0.3 nmol/mg proteinzmin for L-arginine
uptake, and 6.0 6 0.5 and 4.6 6 0.2 nmol/mg proteinzmin for L-leucine
uptake. All the components shown by amino acid inhibition were sta-
tistically different from zero value (Student’s t test; at least p # 0.05).
Similar results were obtained in one to three more independent
experiments.
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expression of the amino acid transport activity associated with
rBAT has been obtained in mammalian cells (e.g. COS cells)
(30). All the data previously reported on the amino acid trans-
port activity associated with rBAT were obtained in Xenopus
oocytes (reviewed in Ref. 41). In addition, the rBAT protein has
a low predicted number of transmembrane domains (25, 27,
28), and indirect evidence suggested its association with an
unidentified subunit of 35–50 kDa to give a putative functional
complex of 125 kDa in kidney and in oocytes expressing rBAT
(Ref. 29).2 All this prompted the hypothesis that rBAT is not an
amino acid transporter by itself, but rather full expression of
the b0,1-like exchanger can only be achieved by association
with an endogenous subunit of the oocyte. In this situation,
description of the amino acid transport activity associated with
rBAT in renal cells was a clear prerequisite for the full under-
standing of the physiopathology of rBAT. The present study
demonstrates that, as in oocytes, rBAT expression is necessary
for the b0,1-like transport activity present in the OK cell line.
Whether rBAT acts as a modulator or as a catalytic component
of this transport activity remains to be established through
reconstitution experiments and identification of the putative
subunit linked to rBAT.
To our knowledge the present study represents the first
description in renal epithelial cells of b0,1-like amino acid
transport activity, defined as high affinity sodium-independent
heteroexchange diffusion for cystine, dibasic (e.g. L-arginine)
and neutral (e.g. leucine) amino acids. Only fragmental views of
this amino acid transport activity have been described in kid-
ney and intestine. Thus, functional studies indicated a high
affinity reabsorption system for L-cystine in the proximal
straight tubule of the nephron (23, 24) (i.e. S3 segment, where
rBAT has been localized; Refs. 6 and 7). This was also shown to
be present in the small intestinal mucosa and to be defective in
biopsies from patients with cystinuria (20, 21, 42). This high
affinity system is shared with dibasic amino acids and shows
heteroexchange diffusion of dibasic amino acids and cystine
(17–19, 42). Transport of L-cystine, examined at low (mM) con-
centration, is inhibited by some L-neutral amino acids, suggest-
ing a high affinity cystine transporter shared with neutral
amino acids (18, 22–24). The sodium dependence of cystine
reabsorption has been controversial for years; the high affinity
cystine uptake in rat brush border membranes was first be-
lieved to be sodium-dependent and, later, sodium-independent
(18, 43). After the molecular identification of rBAT and its role
in type I cystinuria, it was necessary to characterize the amino
acid transport activity associated with rBAT in renal epithelial
cells and test their consistency with the previously reported
data on renal cystine reabsorption. Among the different renal
epithelial cell lines analyzed, thehighaffinity sodium-independ-
ent cystine-dibasic amino acid transport system evidenced in
renal preparations was also substantiated in OK cells (14, 31).
Here we have shown that this transport system is also shared
by neutral amino acids, is due to rBAT expression, and is very
similar, if not identical, to the b0,1-like amino acid exchanger
expressed by rBAT in oocytes.
All the foregoing suggests the following as a plausible de-
scription of the role of rBAT in L-cystine renal reabsorption.
The sodium-independent b0,1-like amino acid exchanger (i.e.
associated to rBAT) is responsible for L-cystine reabsorption in
the brush border of the epithelial cells of the S3 segment of the
nephron; a defect in this reabsorption system causes type I
cystinuria. In contrast to the S3 segment of the nephron, the
bulk of cystine reabsorption occurs in the S1-S2 segment of the
nephron (44), and it seems to be due to a low affinity, high
capacity system that appears to be unshared with dibasic
amino acids and which most probably is sodium-dependent and
not detectable in the small intestine (17–19, 23, 24, 42, 45). Due
to the genetic heterogeneity in cystinuria (11, 12) and the very
mild, if any, alteration of cystine absorption in the small intes-
tine in type III cystinuria, the putative low affinity, high ca-
pacity cystine reabsorption system is an obvious candidate for
this type of cystinuria.
Given that there is no clear agreement on the sodium de-
pendence of the renal reabsorption of cystine, it was suggested
that the main driving force for this reabsorption may be the
intracellular reduction to L-cysteine, which then leaves the cell
by a basolateral transport system (44). The exchange of amino
acids via system b0,1-like in oocytes expressing rBAT (3–5),
and also suggested for this transport activity in OK cells by the
results presented here, offers an additional mechanism of ac-
cumulation for cystine and dibasic amino acids in the brush
border membranes of the epithelial cells of the S3 segment of
the nephron; exchange with intracellular neutral amino acids
could drive the active reabsorption of cystine and dibasic amino
acids. Indeed, rBAT-specific accumulation of cystine occurs in
oocytes where reduction to cysteine is prevented by diamide.1
Reabsorption of cystine and dibasic amino acids through this
exchange may be favored by intracellular reduction of cystine
to cysteine and the negative brush border membrane potential,
respectively. This is consistent with the finding that patients
with type I cystinuria have mutations in the rBAT gene, and
therefore a defective b0,1-like amino acid exchange activity,
and show hyperexcretion of cystine and dibasic amino acids but
not neutral amino acids. This heteroexchange mechanism of
cystine and dibasic amino acid reabsorption could also explain
the enigmatic secretion of cystine exceeding the glomerular
filtration rate in dogs after lysine infusion in vivo (46, 47); the
high concentration of lysine in the glomerular filtrate after
infusion may block by competition the cystine reabsorption
through system b0,1-like in the epithelial cells of the S3 seg-
ment and stimulate the exchange through the brush border
membrane of lysine (inward) and neutral amino acids (out-
ward), including cysteine, which could be oxidized to cystine in
the lumen. The final result would then be a cystine urinary
FIG. 7. Kinetic analysis of L-cystine uptake in OK cells trans-
fected with human rBAT sense or antisense. Uptake of L-[35S]cys-
tine was measured at varying concentrations in the absence of sodium
in the uptake medium, both in OK cells transfected with rBAT-sense
(filled symbols) or with rBAT-antisense (open symbols). Eadie-Hofstee
transformations of 5 mM L-arginine-inhibitable L-cystine uptake are
shown. Uptake values (nmol/mg proteinzmin) are the mean 6 S.E. from
triplicates of a representative experiment. When not visible, S.E. bars
are smaller than symbols.
rBAT Is Responsible for L-Cystine Uptake in OK Cells 10575
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung on O
ctober 4, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
excretion higher than the cystine that reaches the kidney for
glomerular filtration.
Finally, the OK cells could be envisaged as an ideal model
with which to study the cell biology and regulation of this
transport activity associated with rBAT. The b0,1-like amino
acid exchanger seems to be the only transport system for cys-
tine in the apical pole of these cells. Aside from the ontogenic
regulation of rBAT expression in kidney (6), little is known
about the hormonal regulation of this reabsorption system for
cystine and dibasic amino acids.
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